These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2854599)

  • 1. VSV G protein induces murine cytolytic T lymphocytes.
    Reiss CS; Chen SS; Huang AS; Doherty R
    Microb Pathog; 1986 Jun; 1(3):261-7. PubMed ID: 2854599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes.
    Browning M; Reiss CS; Huang AS
    J Virol; 1990 Aug; 64(8):3810-6. PubMed ID: 2164598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.
    Bachmann MF; Hengartner H; Zinkernagel RM
    Med Microbiol Immunol; 1994 Dec; 183(6):315-24. PubMed ID: 7596314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
    Bachmann MF; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen.
    Freer G; Burkhart C; Ciernik I; Bachmann MF; Hengartner H; Zinkernagel RM
    J Virol; 1994 Jun; 68(6):3650-5. PubMed ID: 7910641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats.
    Xue X; Yu Z; Jin H; Liang L; Li J; Li X; Wang Y; Cui S; Li G
    BMC Vet Res; 2021 Jan; 17(1):36. PubMed ID: 33461549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
    Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
    Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
    J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.
    Burkhart C; Freer G; Castro R; Adorini L; Wiesmüller KH; Zinkernagel RM; Hengartner H
    J Virol; 1994 Mar; 68(3):1573-80. PubMed ID: 7508998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus.
    Kündig TM; Castelmur I; Bachmann MF; Abraham D; Binder D; Hengartner H; Zinkernagel RM
    J Virol; 1993 Jun; 67(6):3680-3. PubMed ID: 7684471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of antigen organization on B cell responsiveness.
    Bachmann MF; Rohrer UH; Kündig TM; Bürki K; Hengartner H; Zinkernagel RM
    Science; 1993 Nov; 262(5138):1448-51. PubMed ID: 8248784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral immune responses in CTLA4 transgenic mice.
    Zimmermann C; Seiler P; Lane P; Zinkernagel RM
    J Virol; 1997 Mar; 71(3):1802-7. PubMed ID: 9032309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal.
    Fehr T; Bachmann MF; Bluethmann H; Kikutani H; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Mar; 168(2):184-92. PubMed ID: 8640864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus.
    Gobet R; Cerny A; Rüedi E; Hengartner H; Zinkernagel RM
    Exp Cell Biol; 1988; 56(4):175-80. PubMed ID: 2849570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
    Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
    Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
    Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
    J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
    Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
    J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly synthesized class II MHC chains are required for VSV G presentation to CTL clones.
    Reiss CS; Gapud CP; Keil W
    Cell Immunol; 1992 Jan; 139(1):229-38. PubMed ID: 1309489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.